PTC Therapeutics, Inc. (PTCT)
71.82
-0.88
(-1.20%)
USD |
NASDAQ |
Aug 27, 16:00
71.82
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics EPS Diluted (TTM) : -0.5938 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5938 |
| March 31, 2026 | -2.341 |
| December 31, 2025 | 7.736 |
| September 30, 2025 | 8.556 |
| June 30, 2025 | 6.974 |
| March 31, 2025 | 6.511 |
| December 31, 2024 | -4.730 |
| September 30, 2024 | -5.939 |
| June 30, 2024 | -6.317 |
| March 31, 2024 | -7.686 |
| December 31, 2023 | -8.373 |
| September 30, 2023 | -8.662 |
| June 30, 2023 | -8.424 |
| March 31, 2023 | -7.893 |
| December 31, 2022 | -7.788 |
| September 30, 2022 | -7.463 |
| June 30, 2022 | -7.831 |
| March 31, 2022 | -7.381 |
| December 31, 2021 | -7.434 |
| September 30, 2021 | -6.486 |
| June 30, 2021 | -5.624 |
| March 31, 2021 | -6.727 |
| December 31, 2020 | -6.701 |
| September 30, 2020 | -6.994 |
| June 30, 2020 | -7.027 |
| Date | Value |
|---|---|
| March 31, 2020 | -4.989 |
| December 31, 2019 | -4.474 |
| September 30, 2019 | -4.061 |
| June 30, 2019 | -4.058 |
| March 31, 2019 | -3.517 |
| December 31, 2018 | -2.689 |
| September 30, 2018 | -1.698 |
| June 30, 2018 | -1.456 |
| March 31, 2018 | -1.690 |
| December 31, 2017 | -2.075 |
| September 30, 2017 | -2.885 |
| June 30, 2017 | -3.098 |
| March 31, 2017 | -3.797 |
| December 31, 2016 | -4.17 |
| September 30, 2016 | -4.89 |
| June 30, 2016 | -5.13 |
| March 31, 2016 | -5.13 |
| December 31, 2015 | -5.06 |
| September 30, 2015 | -4.40 |
| June 30, 2015 | -4.06 |
| March 31, 2015 | -3.78 |
| December 31, 2014 | -3.21 |
| September 30, 2014 | -3.12 |
| June 30, 2014 | -2.38 |
| March 31, 2014 | -7.03 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Insmed, Inc. | -4.105 |
| Madrigal Pharmaceuticals, Inc. | -12.88 |
| Protagonist Therapeutics, Inc. | 1.037 |
| Biogen, Inc. | 5.647 |
| BioMarin Pharmaceutical, Inc. | 0.3709 |